3 Reasons to Buy DexCom Stock Like There's No Tomorrow

Medical device specialist DexCom (NASDAQ: DXCM) is going through a rough patch. The company's shares are down sharply year to date due to unimpressive financial results -- and some of the headwinds it has encountered are, no doubt, concerning. The company's slower-than-expected growth in international markets in the second quarter comes to mind.However, there remain excellent reasons to be bullish on DexCom's long-term prospects. Let's consider three of them.DexCom is a leader in the continuous glucose monitoring (CGM) systems market. They aren't the only kinds of devices that help diabetes patients keep track of their blood glucose levels -- a necessary thing to do for many people with this chronic health condition. However, CGMs are, in many ways, superior to their alternatives, blood glucose meters (BGMs). CGMs automatically take measurements throughout the day, up to once every five minutes.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool